Press Releases
Newsletters
Happy New Year! AGT Newsletter – 2020 Edition
A STELLAR 2019 Has Positioned AGT For A SPECTACULAR 2020. I wanted to take a moment to sum up a great year of progress and success at AGT and to talk about potential milestones and significant inflection points ...
AGT Newsletter Volume 8
Featured Stories AGT’s HIV cure program is nearing a major milestone: Investigational New Drug (IND) submission. The IND is the key document that reports the safety data the FDA requires prior to a human trial...
AGT Newsletter Volume 7
Newsletter Vol. 7 In wrapping up the year, AGT was proud to be featured as a State of Maryland “Success Story” for its growth in Maryland and achievements in the gene and cell therapy industry. Watch The Vid...
AGT Newsletter Volume 6
NEWSLETTER VOL. 6 AGT’s progress over the first half of 2018 has been tremendous: six patents granted, major advances in all of its key projects: HIV, PKU and immuno-oncology, substantial momentum on socia...
Latest Videos
Published Articles
Latest From The Blog
Join Our Newsletter
Subscribe to our newsletter to keep up to date with all the latest news about AGT!
Latest AGT Tweets
Can #HIV Be Cured? These Two HIV+ Clinical Trial Participants Believe It Can And So Do We https://t.co/MMFGY4w19G via @YouTube
12 Stocks To Watch As The Race For A Coronavirus Vaccine and Treatment Continues, by @vanjohn10
➠ https://t.co/go6F4WDLwx
#coronavirus #coronavirustreatment #COVID19 #biotechstocks #stocks
$GILD $EBS $REGN $TAK $VIR $BNTX $PFE $INO $NVAX $MRNA $SNY $VXRT
We're #hiring. @americangene is looking for an individual who wants to help transform the #biotech cell and #genetherapy field so we end human suffering caused by harmful viruses.
Click to apply to be a Research & Development Senior Associate #Scientist ~ https://t.co/Itr0of7S5W https://t.co/TMIMfFetdN
